L A Boothby

Summary

Affiliation: Columbus Regional Healthcare System
Country: USA

Publications

  1. ncbi request reprint FDA labeling system for drugs in pregnancy
    L A Boothby
    College of Pharmacy, Auburn University, GA, USA
    Ann Pharmacother 35:1485-9. 2001
  2. ncbi request reprint Bioidentical hormone therapy: a review
    Lisa A Boothby
    Columbus Regional Drug Information Center, Columbus, GA, USA
    Menopause 11:356-67. 2004
  3. ncbi request reprint Acamprosate for the treatment of alcohol dependence
    Lisa A Boothby
    Harrison School of Pharmacy, Auburn University, Alabama, USA
    Clin Ther 27:695-714. 2005
  4. ncbi request reprint Vitamin C and vitamin E for Alzheimer's disease
    Lisa A Boothby
    Harrison School of Pharmacy, Auburn University, AL, USA
    Ann Pharmacother 39:2073-80. 2005
  5. ncbi request reprint Buprenorphine for the treatment of opioid dependence
    Lisa A Boothby
    Drug Information Services, Columbus Regional Healthcare System, 710 Center Street, Columbus, GA 31902, USA
    Am J Health Syst Pharm 64:266-72. 2007
  6. doi request reprint Bioidentical hormone therapy: a panacea that lacks supportive evidence
    Lisa A Boothby
    Auburn University, Harrison School of Pharmacy, Auburn, Alabama, USA
    Curr Opin Obstet Gynecol 20:400-7. 2008

Detail Information

Publications6

  1. ncbi request reprint FDA labeling system for drugs in pregnancy
    L A Boothby
    College of Pharmacy, Auburn University, GA, USA
    Ann Pharmacother 35:1485-9. 2001
    ..To review the current Food and Drug Administration (FDA) pregnancy labeling system, examine the new FDA-proposed pregnancy labeling system for form and content, and provide comments on its suitability for implementation...
  2. ncbi request reprint Bioidentical hormone therapy: a review
    Lisa A Boothby
    Columbus Regional Drug Information Center, Columbus, GA, USA
    Menopause 11:356-67. 2004
    ..Proponents claim that NHT is better tolerated than manufactured products. This paper is intended to review the concept of NHT and to determine whether there is sufficient scientific evidence to support its use...
  3. ncbi request reprint Acamprosate for the treatment of alcohol dependence
    Lisa A Boothby
    Harrison School of Pharmacy, Auburn University, Alabama, USA
    Clin Ther 27:695-714. 2005
    ..Three drug therapies are currently approved by the US Food and Drug Administration (FDA) for this purpose: disulfiram, naltrexone, and acamprosate. The latter was approved by the FDA in 2004...
  4. ncbi request reprint Vitamin C and vitamin E for Alzheimer's disease
    Lisa A Boothby
    Harrison School of Pharmacy, Auburn University, AL, USA
    Ann Pharmacother 39:2073-80. 2005
    ..To evaluate the literature on supplemental vitamin C and vitamin E therapy in the prevention and treatment of Alzheimer's disease (AD)...
  5. ncbi request reprint Buprenorphine for the treatment of opioid dependence
    Lisa A Boothby
    Drug Information Services, Columbus Regional Healthcare System, 710 Center Street, Columbus, GA 31902, USA
    Am J Health Syst Pharm 64:266-72. 2007
    ..The clinical issues surrounding the use of buprenorphine for the treatment of opioid dependence are reviewed...
  6. doi request reprint Bioidentical hormone therapy: a panacea that lacks supportive evidence
    Lisa A Boothby
    Auburn University, Harrison School of Pharmacy, Auburn, Alabama, USA
    Curr Opin Obstet Gynecol 20:400-7. 2008
    ....